Tofflon Science and Technology Group Co., Ltd. (300171.SZ)
CNY 11.75
(0.51%)
CNY 11.75
(0.51%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.64 Billion CNY | 3.15% |
| 2022 | 5.46 Billion CNY | 30.46% |
| 2021 | 4.19 Billion CNY | 54.83% |
| 2020 | 2.7 Billion CNY | 19.6% |
| 2019 | 2.26 Billion CNY | 18.11% |
| 2018 | 1.91 Billion CNY | 11.13% |
| 2017 | 1.72 Billion CNY | 29.9% |
| 2016 | 1.32 Billion CNY | -14.64% |
| 2015 | 1.55 Billion CNY | 23.58% |
| 2014 | 1.25 Billion CNY | 23.27% |
| 2013 | 1.02 Billion CNY | 24.25% |
| 2012 | 821.85 Million CNY | 26.66% |
| 2011 | 648.86 Million CNY | 35.01% |
| 2010 | 480.61 Million CNY | 56.01% |
| 2009 | 308.06 Million CNY | 42.46% |
| 2008 | 216.24 Million CNY | 29.32% |
| 2007 | 167.22 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.18 Billion CNY | 6.62% |
| 2024 Q3 | 1.19 Billion CNY | 1.4% |
| 2024 Q1 | 1.1 Billion CNY | -15.79% |
| 2023 FY | 5.64 Billion CNY | 3.15% |
| 2023 Q3 | 1.37 Billion CNY | -10.05% |
| 2023 Q4 | 1.31 Billion CNY | -4.2% |
| 2023 Q2 | 1.52 Billion CNY | 7.38% |
| 2023 Q1 | 1.42 Billion CNY | -13.89% |
| 2022 Q2 | 1.18 Billion CNY | -3.86% |
| 2022 Q4 | 1.65 Billion CNY | 18.87% |
| 2022 FY | 5.46 Billion CNY | 30.46% |
| 2022 Q1 | 1.23 Billion CNY | -5.56% |
| 2022 Q3 | 1.39 Billion CNY | 16.85% |
| 2021 Q4 | 1.31 Billion CNY | 22.15% |
| 2021 Q2 | 1.09 Billion CNY | 52.54% |
| 2021 FY | 4.19 Billion CNY | 54.83% |
| 2021 Q1 | 716.61 Million CNY | -15.04% |
| 2021 Q3 | 1.07 Billion CNY | -1.88% |
| 2020 Q3 | 675.28 Million CNY | -1.5% |
| 2020 Q4 | 843.48 Million CNY | 24.91% |
| 2020 FY | 2.7 Billion CNY | 19.6% |
| 2020 Q1 | 503.38 Million CNY | -36.62% |
| 2020 Q2 | 685.53 Million CNY | 36.18% |
| 2019 Q2 | 487.07 Million CNY | 11.01% |
| 2019 Q4 | 794.2 Million CNY | 46.01% |
| 2019 Q1 | 438.77 Million CNY | -21.76% |
| 2019 Q3 | 543.94 Million CNY | 11.67% |
| 2019 FY | 2.26 Billion CNY | 18.11% |
| 2018 Q2 | 455.51 Million CNY | -1.33% |
| 2018 Q3 | 438.85 Million CNY | -3.66% |
| 2018 FY | 1.91 Billion CNY | 11.13% |
| 2018 Q1 | 461.65 Million CNY | -12.83% |
| 2018 Q4 | 560.79 Million CNY | 27.79% |
| 2017 Q2 | 334.75 Million CNY | -25.82% |
| 2017 FY | 1.72 Billion CNY | 29.9% |
| 2017 Q1 | 451.24 Million CNY | 32.69% |
| 2017 Q3 | 409.28 Million CNY | 22.27% |
| 2017 Q4 | 529.59 Million CNY | 29.39% |
| 2016 Q4 | 340.07 Million CNY | 30.16% |
| 2016 FY | 1.32 Billion CNY | -14.64% |
| 2016 Q1 | 424.57 Million CNY | -4.67% |
| 2016 Q2 | 301.9 Million CNY | -28.89% |
| 2016 Q3 | 261.27 Million CNY | -13.46% |
| 2015 FY | 1.55 Billion CNY | 23.58% |
| 2015 Q3 | 319.44 Million CNY | -20.51% |
| 2015 Q2 | 401.89 Million CNY | 3.35% |
| 2015 Q4 | 445.35 Million CNY | 39.42% |
| 2015 Q1 | 388.85 Million CNY | 14.68% |
| 2014 Q4 | 339.07 Million CNY | 18.75% |
| 2014 Q3 | 285.53 Million CNY | -14.89% |
| 2014 Q2 | 335.47 Million CNY | 12.34% |
| 2014 Q1 | 298.61 Million CNY | 27.68% |
| 2014 FY | 1.25 Billion CNY | 23.27% |
| 2013 FY | 1.02 Billion CNY | 24.25% |
| 2013 Q2 | 275.66 Million CNY | 8.28% |
| 2013 Q3 | 238.28 Million CNY | -13.56% |
| 2013 Q1 | 254.58 Million CNY | -7.93% |
| 2013 Q4 | 233.87 Million CNY | -1.85% |
| 2012 FY | 821.85 Million CNY | 26.66% |
| 2012 Q1 | 173.39 Million CNY | 7.49% |
| 2012 Q2 | 191.47 Million CNY | 10.43% |
| 2012 Q3 | 180.45 Million CNY | -5.76% |
| 2012 Q4 | 276.52 Million CNY | 53.24% |
| 2011 Q1 | 157.69 Million CNY | 38.92% |
| 2011 FY | 648.86 Million CNY | 35.01% |
| 2011 Q2 | 177.42 Million CNY | 12.51% |
| 2011 Q4 | 161.31 Million CNY | 5.83% |
| 2011 Q3 | 152.42 Million CNY | -14.09% |
| 2010 Q3 | 127.28 Million CNY | 9.73% |
| 2010 Q4 | 113.51 Million CNY | -10.82% |
| 2010 Q2 | 116 Million CNY | -6.3% |
| 2010 FY | 480.61 Million CNY | 56.01% |
| 2010 Q1 | 123.8 Million CNY | 30.86% |
| 2009 Q3 | 67.42 Million CNY | 0.0% |
| 2009 Q4 | 94.61 Million CNY | 40.33% |
| 2009 FY | 308.06 Million CNY | 42.46% |
| 2008 FY | 216.24 Million CNY | 29.32% |
| 2007 FY | 167.22 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 7.89 Billion CNY | 28.499% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 3.36 Billion CNY | -67.641% |
| Blue Sail Medical Co.,Ltd. | 4.92 Billion CNY | -14.504% |
| Andon Health Co., Ltd. | 3.18 Billion CNY | -77.057% |
| Allmed Medical Products Co., Ltd | 2.75 Billion CNY | -104.657% |
| Improve Medical Instruments Co., Ltd. | 644.62 Million CNY | -775.196% |
| Truking Technology Limited | 6.8 Billion CNY | 17.085% |
| Jiangxi Sanxin Medtec Co.,Ltd. | 1.3 Billion CNY | -333.956% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd | 1.46 Billion CNY | -284.424% |
| Autek China Inc. | 1.73 Billion CNY | -224.764% |
| Intco Medical Technology Co., Ltd. | 6.91 Billion CNY | 18.458% |
| Jiangsu Apon Medical Technology Co., Ltd. | 417.98 Million CNY | -1249.749% |
| Winner Medical Co., Ltd. | 8.18 Billion CNY | 31.073% |
| Imeik Technology Development Co.,Ltd. | 2.85 Billion CNY | -97.678% |
| Zhonghong Pulin Medical Products Co., Ltd. | 2.1 Billion CNY | -167.982% |
| Caina Technology Co., Ltd. | 410.47 Million CNY | -1274.446% |